The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis

Published:2018-01-01 Issue:2 Volume:24 Page:213-223
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Ji Yan-Xiao^ORCID,Huang Zan^ORCID,Yang Xia,Wang Xiaozhan,Zhao Ling-Ping,Wang Pi-Xiao,Zhang Xiao-Jing,Alves-Bezerra Michele^ORCID,Cai Lin,Zhang Peng,Lu Yue-Xin,Bai Lan,Gao Mao-Mao,Zhao Huan,Tian Song,Wang Yong,Huang Zhi-Xiang,Zhu Xue-Yong,Zhang Yan,Gong Jun,She Zhi-Gang,Li Feng,Cohen David E,Li Hongliang

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4461.pdf

Reference58 articles.

1. Byrne, C.D. & Targher, G. NAFLD: a multisystem disease. J. Hepatol. 62 (Suppl.), S47–S64 (2015).

2. Rinella, M.E. Nonalcoholic fatty liver disease: a systematic review. J. Am. Med. Assoc. 313, 2263–2273 (2015).

3. Younossi, Z.M. et al. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84 (2016).

4. Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology https://doi.org/10.1002/hep.29367 (2017).

5. Michelotti, G.A., Machado, M.V. & Diehl, A.M. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656–665 (2013).

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Activation of AMPK Prevents Drp1-mediated Mitochondrial Fission and Alleviates Hepatic Steatosis In vitro;Current Molecular Medicine;2024-12

2. TRIM47 inhibits cisplatin chemosensitivity and endoplasmic reticulum stress-induced apoptosis of ovarian cancer cells;Molecular and Cellular Probes;2024-10

3. Cyld restrains the hyperactivation of synovial fibroblasts in inflammatory arthritis by regulating the TAK1/IKK2 signaling axis;Cell Death & Disease;2024-08-09

4. Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice;Biochemical and Biophysical Research Communications;2024-08

5. The deubiquitinating enzyme CYLD impairs NF-κB- and STAT1-dependent macrophage intrinsic immunity toStaphylococcus aureus;2024-07-25